{
  "variant_id": {
    "Gene": "EGFR",
    "Protein_Change": {
      "ref": "G",
      "alt": "D",
      "position": "719"
    },
    "variant_string_id": "EGFR G719D"
  },
  "functional_evidence_aim": "Pathogenic",
  "assessment_steps": [
    {
      "step_name": "Step 1: Define the disease mechanism",
      "extracted_paper_info": "The study investigates the role of EGFR in cancer development, focusing on how mutations affect protein stability and apoptosis inhibition.",
      "judgment": "Yes",
      "reasoning": "The paper clearly defines the disease mechanism linking EGFR mutations to cancer through impaired apoptosis."
    },
    {
      "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
      "extracted_paper_info": "A cycloheximide chase assay was used to measure protein stability, which directly relates to EGFR's functional role in apoptosis inhibition.",
      "judgment": "Yes",
      "reasoning": "The assay is appropriate as it models the disease mechanism by assessing protein stability, a key function of EGFR.",
      "next_step_or_outcome": "Proceed to Step 3"
    },
    {
      "step_name": "Step 3: Evaluate validity of specific instances of assays",
      "extracted_paper_info": "The study included wild-type and known loss-of-function mutants as controls, and experiments were performed in triplicate.",
      "judgment": "Yes",
      "reasoning": "Basic controls (wild-type and mutant) and replicates were included, ensuring the validity of the assay."
    },
    {
      "step_name": "Step 4: Apply evidence to individual variant interpretation",
      "extracted_paper_info": "Statistical analyses were not provided, but two control variants (one benign and one pathogenic) were used.",
      "judgment": "Yes",
      "reasoning": "The number of controls is limited, but the use of known variants provides supporting evidence."
    }
  ],
  "final_evidence_strength": {
    "type": "Pathogenic",
    "strength": "PS3_moderate"
  },
  "overall_conclusion": "The study supports the pathogenicity of EGFR G719D with moderate strength, as it provides appropriate controls and relevant functional assays but lacks detailed statistical analysis."
}